A national survey of Canadian hematologists reveals gaps and variability in supportive care strategies for older adults with ...
Addition of the CDK 4/6 inhibitor improved progression-free survival by 15.2 months for patients with HR+/HER2+ advanced ...
The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...